Skip to Content

Published on September 03, 2013

UHS offers first & only spinal cord stimulation systems for chronic pain designed for full-body magnetic resonance imaging safety

UHS News Release
Release:  Immediately
Mary Birmingham, Practice Administrator, Southern NY Neurosurgical Group,          607-237-1907,
Christina Boyd, VP Community Relations, UHS, 607-762-2336,

September 4, 2013

UHS offers first & only spinal cord stimulation systems for chronic pain designed for full-body magnetic resonance imaging safety
Innovation provides chronic pain patients with SureScan® MRI Systems unprecedented access to standard of diagnostic care

UHS Wilson Medical Center and Southern NY Neurosurgical Group today announced it is offering patients the first and only implantable neurostimulation (also known as spinal cord stimulation, or SCS) systems indicated for use in the treatment of chronic back and/or limb pain that are designed for full-body Magnetic Resonance Imaging (MRI) safety.*

An estimated 100 million Americans are affected by chronic pain,1 and neurostimulation treatment has become a mainstay of chronic pain management. While MRI is a standard of care in the diagnosis and treatment of major health conditions, including cancer, stroke and neurological problems, patients with neurostimulation systems implanted to manage their chronic pain were previously denied an MRI scan due to concerns about the system being affected by the large magnetic fields and radio frequency (RF) energy involved in MRI.

Dr. Khalid Sethi, a board-certified Neurosurgeon with the Southern NY NeuroSurgical Group, is among the first U.S. surgeons to implant a patient with RestoreSensor® SureScan® MRI with Vectris® SureScan® MRI percutaneous leads, one of four Medtronic neurostimulation systems that recently received U.S. Food and Drug Administration (FDA) approval for body MRI scans under specific conditions of use. Other systems enhanced with this technology using the Vectris SureScan MRI percutaneous leads are: PrimeAdvanced® SureScan MRI, RestoreAdvanced® SureScan MRI, and RestoreUltra® SureScan MRI.
“Until now, removal of spinal cord stimulation devices to ensure a safe body MRI scan was unavoidable,” said Dr. Saeed Bajwa of Southern NY NeuroSurgical Group,“With SureScan technology, patients who are receiving SCS therapy to manage their chronic pain now have access to the full benefits of MRI scans without compromising their healthcare, and their physicians have the best opportunity to identify potentially life-threatening medical conditions.”
MRI scans allow physicians to make a wide range of health diagnoses by viewing highly detailed images of internal organs, blood vessels, muscle, joints, tumors, areas of infection and more. MRI utilizes strong magnetic fields and radio frequency pulses to create images of structures inside the body. While CT scans are used for imaging hard materials in the body, like bones, MRI scans are used to image soft tissue.2
As advancements in technology have increased accuracy, effectiveness and patient comfort, MRI use has increased dramatically in recent years. It is estimated that 60 million MRI procedures are performed worldwide each year.3 In the United States, the number of scans has nearly doubled in the past decade, with 32 million scans – more than one MRI per second – performed in 2011.4
UHS is a locally owned, not-for-profit, 916-bed hospital and healthcare system serving Greater Binghamton and surrounding counties. Founded in 1981, UHS provides a full range of medical, surgical, rehabilitative and long-term care services from more than 60 locations around New York’s Southern Tier.

Southern NY NeuroSurgical Group, with offices in Binghamton and Syracuse, is one of the first practices in the United States to implant patients with RestoreSensor SureScan MRI with Vectris SureScan MRI leads. They are also one of the only practices in New York State that offers the full spectrum of Neuromodulation Therapies, including the implantation of Targeted Drug Delivery Pump Systems for Pain and Severe Spasticity.  SNYNG and UHS are among the first in the country to offer the latest in neurosurgical treatment options to patients in Upstate New York.  

Medtronic neurostimulation therapy for chronic pain uses a medical device placed under a patient’s skin to deliver mild electrical impulses to the spinal cord, which block pain signals from reaching the brain. Medtronic’s neurostimulation systems with SureScan MRI technology and Vectris SureScan MRI percutaneous leads are specially designed to reduce or eliminate the hazards produced by the MRI environment. The devices also include a proprietary SureScan feature, which sets the device into an appropriate mode for the MRI environment.

Additional information about Medtronic’s neurostimulation therapies for chronic pain is available at, (607) 729-4942], or by calling 1-800-430-PAIN (7426).

# # #

Media Lounge